ClinicalTrials.Veeva

Menu

Optical Coherence Tomography Angiography in Neurological Disease

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Subarachnoid Hemorrhage
Stroke
Intracerebral Hemorrhage
Octa

Treatments

Device: OCTA

Study type

Observational

Funder types

Other

Identifiers

NCT06797765
STU-2024-0876

Details and patient eligibility

About

Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as intracranial hemorrhage is unclear. Hence, this pilot study will gather preliminary data to support future grant applications to investigate this area more fully by recruiting patients with neurological illness and healthy controls and comparing their OCTA imaging parameters.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Patient admitted to the neuroscience intensive care unit with a diagnosis of: subarachnoid hemorrhage, intracerebral hemorrhage, intracranial aneurysm (ruptured or unruptured), intracranial vascular malformation, ischemic stroke, seizure disorder, intracranial infection, intracranial tumor(s), inflammatory demyelinating disease, traumatic brain injury and/or neuromuscular respiratory failure OR subjects from the community without major neurologic, cardiovascular, pulmonary or metabolic disease

Exclusion criteria

  • Pregnancy
  • Non-English speaking
  • GCS motor score less than 6 (i.e. must be able to follow commands)
  • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Trial design

50 participants in 2 patient groups

Control
Description:
Normal healthy human subjects
Treatment:
Device: OCTA
Patients
Description:
Patients with neurological disease
Treatment:
Device: OCTA

Trial contacts and locations

1

Loading...

Central trial contact

Emily Melikman, MBBS, RN; Noah Jouett, DO, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems